18 studies found for:    diabetes and eye and open and active | Open Studies
Show Display Options
Rank Status Study
1 Recruiting An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.
Conditions: Choroidal Neovascularization;   Macular Edema;   Glaucoma, Neovascular;   Diabetic Retinopathy
Intervention: Drug: ranibizumab
2 Not yet recruiting Early Sleeve Gastrectomy In New Onset Diabetic Obese Patients
Condition: Type 2 Diabetes Mellitus
Interventions: Procedure: Laparoscopic Sleeve Gastrectomy plus conventional medical therapy;   Drug: Conventional medical therapy
3 Unknown  Influence of Acupuncture to Ocular Microcirculation in Patients With Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Intervention: Procedure: acupuncture
4 Unknown  Doppler Ultrasound Investigation of Microcirculations
Condition: Type 1 Diabetes Mellitus
Interventions: Other: Administration ofOxygen and carbon dioxide;   Other: Administration of Oxygen and carbon dioxide
5 Unknown  Acute Changes in Intraocular Cytokines After Intravitreal Bevacizumab
Condition: Complications of Diabetes Mellitus
Intervention: Drug: Intravitreal Avastin injection
6 Recruiting Propranolol for Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Propranolol
Intervention: Drug: CHOLESTYRAMINE
8 Recruiting Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride
Conditions: Type 2 Diabetes;   Hypoglycemia
Interventions: Drug: vildagliptin and metformin (combination);   Drug: glimepiride;   Drug: Metformin
9 Recruiting Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy
Condition: Diabetes
Interventions: Drug: Actos (Pioglitazone);   Drug: Acarbose
10 Not yet recruiting Noctura400 Treatment for Diabetic Retinopathy (CANDLE)
Condition: Diabetic Macular Oedema
Interventions: Device: Noctura 400 Eye Mask;   Drug: Ranibizumab
11 Unknown  Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
Condition: Diabetic Retinopathy
Intervention: Drug: bevacizumab
12 Not yet recruiting Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study
Condition: Diabetic Macular Edema
Interventions: Drug: Tocilizumab;   Drug: Ranibizumab
13 Unknown  Efficacy Study of Diabetes Group Visits
Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: Group Visits
14 Recruiting Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
Conditions: Neovascularization;   Macular Degeneration;   Diabetic Retinopathy;   Retinal Vein Occlusion;   Choroidal Neovascularization;   Retinal Neovascularization
Intervention: Drug: ziv-aflibercept
15 Recruiting Prevention of Microvascular Complications in Overweight Diabetics With Surgery or Best Medicine
Condition: Diabetic Kidney Disease
Interventions: Procedure: Optimal medical treatment and surgery;   Procedure: Optimal medical treatment
16 Recruiting Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Condition: Proliferative Diabetic Retinopathy (PDR)
Interventions: Drug: Ranibizumab;   Procedure: Laser photocoagulation;   Procedure: Ranibizumab & laser photocoagulation
17 Not yet recruiting Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa
Condition: Diabetic Macular Oedema
Interventions: Device: Navigated laser;   Device: Conventional laser
18 Not yet recruiting Variable Interval Versus Set Interval Aflibercept for DME
Conditions: Cystoid Macular Edema;   Diabetic Macular Edema
Intervention: Drug: Intravitreal Aflibercept Injection

Indicates status has not been verified in more than two years